National agreements were also signed in South Africa, Australia and Italy. In other countries, individual breeders have signed license agreements, including over 300 breeders and breeding companies in the United States. The Innovations Foundation has licensed five laboratories in North America and eight others worldwide to conduct the HAL-1843 test. These laboratories certify their test results so that breeders can advertise the status of their pigs and the offspring. The goal of this novel technology is to use Verotoxin to selectively target and kill cancer cells in the patient's bone marrow, without harming the essential marrow cells that allow healthy cells to regenerate.
Clinical trials are ongoing, and have produced optimistic results to date.
The Endopore dental implant was developed in the 1980s at the University of Toronto by surgeons in the Faculty of Dentistry and a professor at the Centre for Biomaterials. It is radically different from the existing systems on the market. In 1998, after successful clinical trials, the Innovations Foundation helped the university reach a license agreement with Innova Life Sciences Corporation to commercialize, manufacture and sell the Endopore implant. Innova has exclusive worldwide rights to the Endopore system until 2010. Dentists now using the Endopore implant are excited by the system's benefits and have concluded that it is superior to existing systems.